APA (7th ed.) Citation

SF, L. M., SA, L., B, C., A, P., JH, K., NL, P., . . . JI, A. (2025). SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk. Antioxidants (Basel, Switzerland), 14(12), . https://doi.org/10.3390/antiox14121388

Chicago Style (17th ed.) Citation

SF, López Moreno, et al. "SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk." Antioxidants (Basel, Switzerland) 14, no. 12 (2025). https://doi.org/10.3390/antiox14121388.

MLA (9th ed.) Citation

SF, López Moreno, et al. "SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk." Antioxidants (Basel, Switzerland), vol. 14, no. 12, 2025, https://doi.org/10.3390/antiox14121388.